 Scott Alper
Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunity, Innate | 17 | 2024 | 846 | 3.470 |
Why?
| | Myelodysplastic Syndromes | 5 | 2026 | 147 | 3.090 |
Why?
| | Alternative Splicing | 7 | 2026 | 249 | 2.620 |
Why?
| | Macrophages | 15 | 2026 | 1514 | 2.360 |
Why?
| | RNA Splicing | 8 | 2023 | 287 | 2.260 |
Why?
| | Myeloid Differentiation Factor 88 | 6 | 2026 | 117 | 2.190 |
Why?
| | Toll-Like Receptors | 5 | 2026 | 194 | 2.160 |
Why?
| | RNA Precursors | 4 | 2022 | 156 | 1.940 |
Why?
| | Caenorhabditis elegans | 10 | 2018 | 337 | 1.870 |
Why?
| | RNA Splicing Factors | 4 | 2020 | 65 | 1.400 |
Why?
| | Serine-Arginine Splicing Factors | 2 | 2024 | 27 | 1.370 |
Why?
| | RNA Interference | 10 | 2018 | 476 | 1.180 |
Why?
| | Lipopolysaccharides | 9 | 2024 | 863 | 1.120 |
Why?
| | Phosphoproteins | 3 | 2020 | 346 | 1.120 |
Why?
| | Toll-Like Receptor 4 | 6 | 2025 | 276 | 1.040 |
Why?
| | Caenorhabditis elegans Proteins | 7 | 2013 | 210 | 1.030 |
Why?
| | RNA, Messenger | 6 | 2026 | 2833 | 1.000 |
Why?
| | Inflammation | 12 | 2024 | 2881 | 0.980 |
Why?
| | Signal Transduction | 13 | 2026 | 5239 | 0.950 |
Why?
| | Ribonucleoprotein, U2 Small Nuclear | 2 | 2015 | 5 | 0.850 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein U | 1 | 2024 | 7 | 0.820 |
Why?
| | Splicing Factor U2AF | 2 | 2023 | 18 | 0.780 |
Why?
| | RAW 264.7 Cells | 5 | 2024 | 50 | 0.750 |
Why?
| | Spliceosomes | 2 | 2020 | 53 | 0.730 |
Why?
| | GTPase-Activating Proteins | 2 | 2013 | 82 | 0.720 |
Why?
| | Mutation | 8 | 2026 | 4104 | 0.690 |
Why?
| | Cytokines | 7 | 2020 | 2066 | 0.690 |
Why?
| | RNA, Small Interfering | 4 | 2018 | 635 | 0.640 |
Why?
| | Macrophages, Alveolar | 3 | 2020 | 368 | 0.640 |
Why?
| | Mice | 21 | 2026 | 18394 | 0.630 |
Why?
| | Animals | 32 | 2026 | 38177 | 0.620 |
Why?
| | Gene Expression | 3 | 2020 | 1490 | 0.620 |
Why?
| | RNA-Binding Proteins | 1 | 2024 | 464 | 0.610 |
Why?
| | Genomics | 3 | 2018 | 842 | 0.590 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2023 | 684 | 0.480 |
Why?
| | Gram-Positive Bacteria | 1 | 2016 | 47 | 0.480 |
Why?
| | Foreign-Body Reaction | 3 | 2025 | 36 | 0.480 |
Why?
| | NF-kappa B | 1 | 2020 | 662 | 0.480 |
Why?
| | Stem Cells | 1 | 2020 | 627 | 0.470 |
Why?
| | Monocytes | 1 | 2018 | 538 | 0.440 |
Why?
| | Leukocytes, Mononuclear | 1 | 2017 | 573 | 0.430 |
Why?
| | Toll-Like Receptor 2 | 2 | 2025 | 126 | 0.420 |
Why?
| | Ribonucleoprotein, U5 Small Nuclear | 1 | 2013 | 11 | 0.410 |
Why?
| | Peptide Elongation Factors | 1 | 2013 | 15 | 0.410 |
Why?
| | Adaptive Immunity | 1 | 2015 | 169 | 0.400 |
Why?
| | Lung | 2 | 2026 | 4112 | 0.390 |
Why?
| | Implants, Experimental | 2 | 2025 | 21 | 0.370 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 54 | 0.370 |
Why?
| | Cell Line | 6 | 2018 | 2882 | 0.370 |
Why?
| | Disease Models, Animal | 2 | 2026 | 4580 | 0.370 |
Why?
| | Bacteria | 1 | 2018 | 891 | 0.350 |
Why?
| | Germ Cells | 1 | 2009 | 66 | 0.300 |
Why?
| | Polyethylene Glycols | 3 | 2025 | 655 | 0.290 |
Why?
| | Longevity | 1 | 2009 | 174 | 0.270 |
Why?
| | Alarmins | 2 | 2025 | 27 | 0.260 |
Why?
| | Hydrogels | 3 | 2025 | 701 | 0.250 |
Why?
| | Humans | 19 | 2026 | 145305 | 0.250 |
Why?
| | Inflammation Mediators | 2 | 2020 | 509 | 0.240 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2026 | 40 | 0.240 |
Why?
| | Leukocytes | 1 | 2026 | 295 | 0.210 |
Why?
| | Phagocytosis | 1 | 2026 | 299 | 0.210 |
Why?
| | Antimicrobial Cationic Peptides | 2 | 2020 | 86 | 0.210 |
Why?
| | Transfection | 2 | 2018 | 940 | 0.200 |
Why?
| | Prostheses and Implants | 1 | 2025 | 141 | 0.200 |
Why?
| | Biocompatible Materials | 2 | 2025 | 436 | 0.200 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2026 | 636 | 0.200 |
Why?
| | Macrophage Activation | 2 | 2022 | 193 | 0.200 |
Why?
| | Oligonucleotide Array Sequence Analysis | 4 | 2012 | 758 | 0.190 |
Why?
| | Chemotaxis | 1 | 2023 | 122 | 0.190 |
Why?
| | Gene Expression Regulation | 4 | 2020 | 2609 | 0.190 |
Why?
| | Genes, Helminth | 1 | 2002 | 30 | 0.180 |
Why?
| | Protein Isoforms | 1 | 2024 | 402 | 0.180 |
Why?
| | Genes, Homeobox | 1 | 2002 | 50 | 0.180 |
Why?
| | HEK293 Cells | 1 | 2024 | 744 | 0.170 |
Why?
| | Mice, Inbred C57BL | 6 | 2025 | 6007 | 0.170 |
Why?
| | Sulfhydryl Compounds | 1 | 2023 | 189 | 0.170 |
Why?
| | Neutrophils | 2 | 2025 | 1135 | 0.170 |
Why?
| | Nontuberculous Mycobacteria | 2 | 2020 | 210 | 0.160 |
Why?
| | Foreign Bodies | 1 | 2022 | 107 | 0.160 |
Why?
| | Membrane Lipids | 1 | 2020 | 83 | 0.150 |
Why?
| | Immune Evasion | 1 | 2020 | 64 | 0.150 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2019 | 22 | 0.150 |
Why?
| | Transcription Factors | 2 | 2009 | 1746 | 0.150 |
Why?
| | Gene Expression Profiling | 3 | 2018 | 1787 | 0.140 |
Why?
| | K562 Cells | 1 | 2019 | 93 | 0.140 |
Why?
| | Metabolic Networks and Pathways | 1 | 2020 | 187 | 0.140 |
Why?
| | Phospholipids | 1 | 2020 | 214 | 0.140 |
Why?
| | Cell Differentiation | 1 | 2026 | 2053 | 0.140 |
Why?
| | Mice, Transgenic | 1 | 2023 | 2192 | 0.140 |
Why?
| | Mice, Inbred Strains | 2 | 2016 | 397 | 0.130 |
Why?
| | HLA-DR Antigens | 1 | 2018 | 220 | 0.130 |
Why?
| | Virulence Factors | 1 | 2018 | 174 | 0.120 |
Why?
| | Disease Susceptibility | 1 | 2018 | 348 | 0.120 |
Why?
| | Transcription, Genetic | 3 | 2020 | 1496 | 0.120 |
Why?
| | Mice, Knockout | 3 | 2025 | 3127 | 0.120 |
Why?
| | Phenotype | 3 | 2019 | 3172 | 0.120 |
Why?
| | Cell Fusion | 2 | 2008 | 49 | 0.110 |
Why?
| | Respiratory Mucosa | 1 | 2018 | 322 | 0.110 |
Why?
| | Recombinant Fusion Proteins | 2 | 2008 | 675 | 0.110 |
Why?
| | Anti-Inflammatory Agents | 1 | 2018 | 475 | 0.110 |
Why?
| | Male | 6 | 2026 | 72628 | 0.100 |
Why?
| | Comparative Genomic Hybridization | 1 | 2013 | 28 | 0.100 |
Why?
| | Introns | 1 | 2015 | 254 | 0.100 |
Why?
| | Chemokines | 1 | 2014 | 218 | 0.100 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 336 | 0.100 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2018 | 368 | 0.100 |
Why?
| | Blotting, Western | 2 | 2012 | 1187 | 0.090 |
Why?
| | Female | 4 | 2026 | 78605 | 0.090 |
Why?
| | Staphylococcus aureus | 1 | 2016 | 461 | 0.090 |
Why?
| | Staphylococcal Infections | 1 | 2016 | 391 | 0.090 |
Why?
| | Middle Aged | 3 | 2026 | 36021 | 0.090 |
Why?
| | Genome-Wide Association Study | 2 | 2016 | 1414 | 0.090 |
Why?
| | Pseudomonas aeruginosa | 2 | 2009 | 356 | 0.080 |
Why?
| | Serratia marcescens | 1 | 2009 | 18 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 851 | 0.080 |
Why?
| | Forkhead Transcription Factors | 1 | 2009 | 202 | 0.070 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 266 | 0.070 |
Why?
| | Biological Evolution | 1 | 2012 | 489 | 0.070 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2009 | 146 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2009 | 292 | 0.070 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2008 | 157 | 0.070 |
Why?
| | Fibrosis | 2 | 2022 | 550 | 0.070 |
Why?
| | Smoke | 1 | 2009 | 148 | 0.070 |
Why?
| | Protein Interaction Mapping | 1 | 2008 | 105 | 0.070 |
Why?
| | Chromosomes | 1 | 2008 | 108 | 0.070 |
Why?
| | Models, Animal | 1 | 2009 | 392 | 0.070 |
Why?
| | Larva | 1 | 2008 | 244 | 0.060 |
Why?
| | Cadmium | 1 | 2007 | 69 | 0.060 |
Why?
| | Organ Specificity | 1 | 2007 | 313 | 0.060 |
Why?
| | Phosphorylation | 1 | 2009 | 1735 | 0.060 |
Why?
| | Models, Genetic | 1 | 2007 | 536 | 0.050 |
Why?
| | Acrylates | 1 | 2023 | 48 | 0.050 |
Why?
| | Amides | 1 | 2023 | 101 | 0.050 |
Why?
| | Zinc Fingers | 1 | 2002 | 53 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2002 | 277 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2002 | 396 | 0.040 |
Why?
| | Epidermis | 1 | 2002 | 157 | 0.040 |
Why?
| | Epithelial Cells | 1 | 2008 | 1126 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 2002 | 541 | 0.040 |
Why?
| | Aged | 2 | 2018 | 26001 | 0.040 |
Why?
| | Chromatography, Thin Layer | 1 | 2020 | 27 | 0.040 |
Why?
| | THP-1 Cells | 1 | 2020 | 20 | 0.040 |
Why?
| | Cathelicidins | 1 | 2020 | 41 | 0.040 |
Why?
| | Virulence | 1 | 2020 | 280 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 983 | 0.040 |
Why?
| | Species Specificity | 1 | 2020 | 574 | 0.040 |
Why?
| | Base Sequence | 1 | 2002 | 2191 | 0.040 |
Why?
| | Amino Acid Sequence | 1 | 2002 | 2158 | 0.030 |
Why?
| | Molecular Sequence Data | 1 | 2002 | 2931 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2018 | 4155 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2002 | 909 | 0.030 |
Why?
| | Cell Membrane | 1 | 2020 | 708 | 0.030 |
Why?
| | Phylogeny | 1 | 2020 | 1020 | 0.030 |
Why?
| | Escherichia coli | 1 | 2020 | 855 | 0.030 |
Why?
| | Adult | 1 | 2018 | 40627 | 0.030 |
Why?
| | Poly I-C | 1 | 2011 | 57 | 0.020 |
Why?
| | Smoking | 1 | 2018 | 1472 | 0.020 |
Why?
| | E2F1 Transcription Factor | 1 | 2010 | 68 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 2010 | 251 | 0.020 |
Why?
| | Chemokine CXCL1 | 1 | 2009 | 76 | 0.020 |
Why?
| | Hedgehog Proteins | 1 | 2010 | 197 | 0.020 |
Why?
| | Cotinine | 1 | 2009 | 79 | 0.020 |
Why?
| | Ligands | 1 | 2011 | 676 | 0.020 |
Why?
| | Bone Marrow | 1 | 2010 | 306 | 0.020 |
Why?
| | Spleen | 1 | 2010 | 508 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2009 | 510 | 0.020 |
Why?
| | Genetic Loci | 1 | 2009 | 261 | 0.020 |
Why?
| | Nicotine | 1 | 2009 | 332 | 0.020 |
Why?
| | Survival Rate | 1 | 2010 | 2100 | 0.010 |
Why?
| | Computational Biology | 1 | 2009 | 683 | 0.010 |
Why?
| | DNA | 1 | 2011 | 1467 | 0.010 |
Why?
| | Gene Regulatory Networks | 1 | 2007 | 321 | 0.010 |
Why?
| | Liver | 1 | 2010 | 1893 | 0.010 |
Why?
| | Biomarkers | 1 | 2010 | 4284 | 0.010 |
Why?
|
|
Alper's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|